Johnson & Johnson Raises Full-Year Earnings Guidance After Q3 Beat
Johnson & Johnson reported third-quarter adjusted earnings of $2.59 per share, above expectations, and raised its full-year outlook. Medical technology business stumbles left investors lukewarm.
Story updates
11:07:16 AM UTC
SquawkNews
Johnson & Johnson raised its full-year 2026 guidance following third-quarter results that showed accelerating momentum. The company now expects adjusted operational sales growth of 6.4% to 6.8% for the year, up from its prior forecast of 6.2% to 6.8%. Adjusted EPS guidance increased by $0.06 to a m…
59 a share, ahead of Wall Street'…